Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
2019-06-24
Target enrollment:
Participant gender:
Summary
Efficacy and safety of HCP1102 in patients with perennial allergic rhinitis :
A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial